A genetic mutation that promotes cancer development blocks the normal sorting of a protein called “Argonaute 2.”

Researchers at Columbia and Vanderbilt universities have made an important discovery in mice that has implications for understanding the gastrointestinal (GI) problems experienced by some children with autism.

Jesse Ehrenfeld, M.D., MPH, associate professor of Anesthesiology, Biomedical Informatics, Surgery and Health Policy, has been named director of education research for the Office of Health Sciences Education.

Chronic obstructive pulmonary disease (COPD) is a common smoking-related lung illness and the third leading cause of death in the United States. Scientists have long believed that inhaling toxic gases and particles from tobacco smoke causes inflammation of the small airways in the lungs, leading to the development of COPD.

An expert in the dynamic behavior of the microtubule cytoskeleton at Vanderbilt University is among 15 scientists in the chemical and biological sciences nationwide who have been named 2016 Searle Scholars.

A startup veteran and investor whose ventures range from retail to manufacturing joined Vanderbilt University this spring as the inaugural executive director of the newly created Innovation Center. Robert Grajewski joined Vanderbilt as the Evans Family Executive Director of the Innovation Center on April 1. The Innovation Center, set to open late summer, will support a maker culture that encourages innovation and creativity and bolsters implementation of the four intersecting themes that make up the university’s Academic Strategic Plan.

A targeted therapy for triple-negative breast cancer (TNBC), the most aggressive form of breast cancer, has shown potential promise in a recently published study. TNBC is the only type of breast cancer for which there are no currently approved targeted therapies.